Stay updated with breaking news from Windlass biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It's IPOs ahoy! 40-odd issues on the way to mop up Rs 80,000 crore indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
It's IPOs ahoy! 40-odd issues on the way to mop up Rs 80,000 crore newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.
The proposed flotation, if successful, would be the largest such offer beating Coal India’s Rs 15,200 crore-IPO in 2010, the country’s largest till date ....
Amidst the raging second wave of the COVID-19 pandemic and many fearing a third wave, the healthcare sector is in the limelight for the second consecutive year as several pharma and life sciences companies are lined up to tap the equity markets through IPOs over the next few months, according to investment bankers. Five such companies which have firmed up their initial public offering (IPO) plans are Glenmark Lifesciences, a fully-owned arm of Glenmark Pharmaceuticals, the city-based bulk drugs firm Supriya Lifesciences, drug formulations firm Windlass Biotech, Bain Capital-backed Emcure Pharma and CX Partners-funded Veeda Clinical Research. According to investment-bankers, they are planning to mop up over Rs 7,000 crore in primary share sales. ....